MetaADEDB 2.0 @ LMMD
bromfenac
(BIYQNLJPABKADF-UHFFFAOYSA-M)
Structure
SMILES
[O-]C(=O)Cc1cccc(c1N)C(=O)c1ccc(cc1)Br.O.[Na+]
Molecular Formula:
C15H13BrNNaO4
Molecular Weight:
374.162
Log P:
2.0716
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
92.45
CAS Number(s):
120638-55-3
Synonym(s)
1.
bromfenac
2.
AHR-10282
3.
Duract
4.
ISV-303
5.
Xibrom
6.
bromfenac sodium
7.
sodium bromfenac
External Link(s)
MeSHC053083
PubChem Compound23663409
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Mental status changesFAERS: 4US FAERS
2NauseaFAERS: 4US FAERS
3Punctate keratitisFAERS: 4US FAERS
4jaundiceFAERS: 4US FAERS
5Abdominal PainFAERS: 3US FAERS
6Corneal OpacityFAERS: 3US FAERS
7AnorexiaFAERS: 2US FAERS
8AstheniaFAERS: 2US FAERS
9ColitisFAERS: 2US FAERS
10NervousnessFAERS: 2US FAERS
11UlcerFAERS: 2US FAERS
12Weight decreasedFAERS: 2US FAERS
13Activities of daily living impairedFAERS: 1US FAERS
14ArthralgiaFAERS: 1US FAERS
15AsthmaFAERS: 1US FAERS
16BlepharitisFAERS: 1US FAERS
17CataractFAERS: 1US FAERS
18Diabetic RetinopathyFAERS: 1US FAERS
19Eye irritationFAERS: 1US FAERS
20Eyelids pruritusFAERS: 1US FAERS
21FatigueFAERS: 1US FAERS
22General physical health deteriorationFAERS: 1US FAERS
23GlaucomaFAERS: 1US FAERS
24HeadacheFAERS: 1US FAERS
25IritisFAERS: 1US FAERS
26MalaiseFAERS: 1US FAERS
27Pharmaceutical product complaintFAERS: 1US FAERS
28Posterior capsule opacificationFAERS: 1US FAERS
29Retinal Artery OcclusionFAERS: 1US FAERS
30Therapy non-responderFAERS: 1US FAERS
31UveitisFAERS: 1US FAERS
32VomitingFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.